CoChat

Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model

Open access
Park, Soyoung, Kang, Jihee, Choi, Sanghaeng, Park, Haryung, Hwang, Eunchong, Kang, Yoongu, Kim, Aram, Holzapfel, Wilhelm, Ji, Yosep · 2018 · PLOS ONE
Cited by 70

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Thanks to recent scientific progress a relationship between the intestinal microbiota and metabolic diseases could be established. A deeper understanding of underlying mechanisms has opened ways towards new approaches for alleviating conditions associated with metabolic diseases. Dysbiosis appears to be a major underlying factor associated with metabolic syndrome and related adverse health conditions. A major focus has therefore shifted to controlling of the gut microbiota through administration of functional lactic acid bacteria (LAB). The scope for health promotion and/or support by probiotics such as LAB has thereby been widened beyond the improving of intestinal health, also to include anti-obesity, anti-diabetic and cholesterol-lowering effects. In this study we investigated the cholesterol-lowering and microbiota modulatory potential of a LAB strain, Lactobacillus rhamnosus BFE5264, isolated from Maasai fermented milk. A mouse model receiving a high-cholesterol diet served as model for evaluating its functionality. The administration of L. rhamnosus BFE5264 resulted in a significant reduction of the serum cholesterol level that was accompanied by changes in intestinal microbiota and the production of short chain fatty acid (SCFA) in comparison to the control group. This strain also beneficially influenced the regulation of cholesterol metabolism in the liver in a pattern similar to that resulting from statin treatment, a drug inhibiting cholesterol biosynthesis in the liver.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0203150

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 21

  1. MJ Butel, 2014, Probiotics, gut microbiota and health, Médicine et maladies infectieuses, 44, 1, 10.1016/j.medmal.2013.10.002 · DOI · Paper page
  2. CA Lozupone, 2012, Diversity, stability and resilience of the human gut microbiota, Nature, 489, 220, 10.1038/nature11550 · DOI · Paper page
  3. G Cammarota, 2014, Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation?, Internal and emergency medicine journal, 9, 365, 10.1007/s11739-014-1069-4 · DOI
  4. J Wang, 2015, Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice, ISME journal, 9, 1, 10.1038/ismej.2014.99 · DOI · Paper page
  5. T Arora, 2016, The gut microbiota and metabolic disease: current understanding and future perspectives, Journal of internal medicine, 280, 339, 10.1111/joim.12508 · DOI · Paper page
  6. M Remely, 2014, Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity, Gene, 537, 85, 10.1016/j.gene.2013.11.081 · DOI · Paper page
  7. S Mora, 2015, Effects of short chain fatty acids on glucose and lipid metabolism in adipocytes, The FASEB Journal, 29, 672
  8. HV Lin, 2012, Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms, PLoS One, 7, e35240, 10.1371/journal.pone.0035240 · DOI · Paper page
  9. C Demigné, 1995, Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes, British journal of nutrition, 74, 209, 10.1079/BJN19950124 · DOI · Paper page
  10. K Weitkunat, 2016, Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high-fat diet-induced obesity, Molelcular Nutrition and Food Research, 60, 2611, 10.1002/mnfr.201600305 · DOI · Paper page
  11. JM Mathara, 2008, Functional characteristics of Lactobacillus spp. from traditional Maasai fermented milk products in Kenya, International Journal of Food Microbiology, 126, 57, 10.1016/j.ijfoodmicro.2008.04.027 · DOI · Paper page
  12. F Patrignani, 2006, Potential of functional strains, isolated from traditional Maasai milk, as starters for the production of fermented milks, International Journal of Food Microbiology, 107, 1, 10.1016/j.ijfoodmicro.2005.08.004 · DOI
  13. HS Yoon, 2013, The probiotic Lactobacillus rhamnosus BFE5264 and Lactobacillus plantarum NR74 promote cholesterol efflux and suppress inflammation in THP-1 cells, Journal of the Science of Food and Agriculture, 93, 781, 10.1002/jsfa.5797 · DOI
  14. HS Yoon, 2011, Lactobacillus rhamnosus BFE 5264 and Lactobacillus plantarum NR74 Promote Cholesterol Excretion Through the Up-Regulation of ABCG5/8 in Caco-2 Cells, Probiotics and antimicrobial proteins, 3, 194, 10.1007/s12602-011-9086-3 · DOI
  15. M Kumar, 2012, Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases, Experimental diabetes research, 2012, 10.1155/2012/902917 · DOI · Paper page
  16. L-G Ooi, 2010, Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings, International journal of molecular sciences, 11, 2499, 10.3390/ijms11062499 · DOI · Paper page
  17. S Anandaraja, 2005, Low-density lipoprotein cholesterol estimation by a new formula in Indian population, International journal of cardiology, 102, 117, 10.1016/j.ijcard.2004.05.009 · DOI
  18. GV Mann, 1974, Studies of a surfactant and cholesteremia in the Maasai, The American journal of clinical nutrition, 27, 464, 10.1093/ajcn/27.5.464 · DOI · Paper page
  19. M Eichholzer, 1993, Is there a hypocholesterolemic factor in milk and milk products?, International journal for vitamin and nutrition research; Internationale Zeitschrift fur Vitamin- und Ernährungsforschung; Journal international de vitaminologie et de nutrition, 63, 159
  20. L Sheng, 2017, Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation, Scientific reports, 7, 1748, 10.1038/s41598-017-01576-9 · DOI · Paper page
  21. JE Bueld, 1996, Effects of Propionic Acid and Pravastatin on HMGCoA Reductase Activity in Relation to Forestomach Lesions in the Rat, Pharmacology and toxicology, 78, 229, 10.1111/j.1600-0773.1996.tb00210.x · doi:10.1111/j.1600-0773.1996.tb00210.x

Cited by

See all 70

Metadata

Authors
Park, S., Kang, J., Choi, S., Park, H., Hwang, E., Kang, Y., Kim, A., Holzapfel, W., & Ji, Y.
Venue
PLOS ONE
Published
2018-08-28
Volume
13
Issue
8
Pages
e0203150
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2888879857
Cited by
70
References
6
FWCI
6.68
Type
journal article
Language
en
Open access
gold
Funders
Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (916001-2)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model. https://app.cochat.ai/papers/10.1371/journal.pone.0203150
The paper
Park, S., Kang, J., Choi, S., Park, H., Hwang, E., Kang, Y., Kim, A., Holzapfel, W., & Ji, Y. (2018). Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model. PLOS ONE. https://doi.org/10.1371/journal.pone.0203150

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.